Focus: Ceribell is a medical device biotech specializing in rapid EEG (electroencephalogram) systems for neurological monitoring, particularly in intensive care and acute neurology settings. The company operates at the intersection of neurology and ophthalmology with a focus on point-of-care diagnostic devices.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Hot — 52 jobs added in 30d
Net +31 (52 new, 21 removed). Aggressive expansion phase.
Ceribell is a commercial-stage medical device company with strong hiring momentum, best suited for go-to-market, clinical operations, and device commercialization roles rather than drug discovery-focused careers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ceribell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ceribell's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles